Reference
Urbanska E, et al. Changing Resistance Mechanisms in Rebiopsies of ALK-Positive NSCLC During Multiple Lines of Therapy: ALK/BRAF-Mutations Followed By EMT. Journal of Thoracic Oncology 13 (Suppl.): S946 abstr. P3.08-18, No. 10, Oct 2018. Available from: URL: http://doi.org/10.1016/j.jtho.2018.08.1769 [abstract] - Denmark
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1728, 49 (2018). https://doi.org/10.1007/s40278-018-54312-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-54312-6